Unbound MEDLINE

Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.

Abstract

The Islamic Hajj to Makkah (Mecca) has been associated with outbreaks of invasive meningococcal disease and the global spread of Neisseria meningitidis serogroup W-135. For Hajj pilgrims the quadrivalent vaccination against serogroups A, C, W-135 and Y is a mandatory requirement. Novel conjugate vaccines may provide benefits for the community by reduction of carriage. With the introduction of the new generation of quadrivalent meningococcal conjugate vaccines (Menveo, Menactra, and others pending license) and their recent implementation in Saudi Arabia, experts from 11 countries in the Middle East region met at a Meningococcal Leadership Forum (MLF), in Dubai in May 2010 to exchange opinions on meningococcal disease and prevention strategies. These experts discussed the importance of introducing conjugate vaccines for pilgrims and travellers, and elaborated a consensus recommendation to support healthcare professionals and decision-makers.

Links

  • Aggregator Full Text
  • Authors

    Shibl A, Tufenkeji H, Khalil M, Memish Z, Meningococcal Leadership Forum (MLF) Expert Group

    Source

    Eastern Mediterranean health journal = La revue de santé de la Méditerranée orientale = al-Majallah al-ṣiḥḥīyah li-sharq al-mutawassiṭ 19:4 2013 Apr pg 389-92

    MeSH

    Consensus
    Disease Outbreaks
    Guidelines as Topic
    Humans
    Islam
    Meningococcal Infections
    Meningococcal Vaccines
    Middle East
    Neisseria meningitidis, Serogroup W-135
    Saudi Arabia
    Travel

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    23882966